APA

Weaver J. L., Contrera J. F., Rosenzweig B. A., Thompson K. L., Faustino P. J., Strong J. M., Ellison C. D., Anderson L. W., Prasanna H. R., Long-Bradley P. E., Lin K. K., Zhang J. & Sistare F. D. (19981116). An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype. : Toxicologic pathology.

Chicago

Weaver J L, Contrera J F, Rosenzweig B A, Thompson K L, Faustino P J, Strong J M, Ellison C D, Anderson L W, Prasanna H R, Long-Bradley P E, Lin K K, Zhang J and Sistare F D. 19981116. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype. : Toxicologic pathology.

Harvard

Weaver J. L., Contrera J. F., Rosenzweig B. A., Thompson K. L., Faustino P. J., Strong J. M., Ellison C. D., Anderson L. W., Prasanna H. R., Long-Bradley P. E., Lin K. K., Zhang J. and Sistare F. D. (19981116). An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype. : Toxicologic pathology.

MLA

Weaver J L, Contrera J F, Rosenzweig B A, Thompson K L, Faustino P J, Strong J M, Ellison C D, Anderson L W, Prasanna H R, Long-Bradley P E, Lin K K, Zhang J and Sistare F D. An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype. : Toxicologic pathology. 19981116.